SCHEMBL22195391

SCHEMBL22195391

C[C@H](O)[C@@H]1NC(=O)[C@H]2Cc3cn(nn3)CCC[C@@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N(C)[C@@H](Cc3ccc(O)cc3)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](CSSCC(NC(=O)CN)C(=O)N2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC1=O

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRNA10 Q9GZZ6 3/20 0.60
CHRNA9 Q9UGM1 3/20 0.60
CHRNA7 P36544 2/20 0.60
KLK5 Q9Y337 9/20 0.55
ACE P12821 1/20 0.52
ACE2 Q9BYF1 1/20 0.52
KLKB1 P03952 1/20 0.52
PCSK9 Q8NBP7 1/20 0.50
F12 P00748 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22195295 0.95 CHRNA10 (0.65) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195334 0.95 CHRNA10 (0.61) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195285 0.95 CHRNA10 (0.61) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195307 0.95 KLK5 (0.57) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195282 0.95 CHRNA10 (0.62) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195292 0.94 CHRNA10 (0.64) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195323 0.93 CHRNA10 (0.62) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22195304 0.93 CHRNA10 (0.62) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22280522 0.93 CHRNA10 (0.62) CHRNA10CHRNA9CHRNA7KLK5ACE
SCHEMBL22280333 0.93 CHRNA10 (0.64) CHRNA10CHRNA9CHRNA7KLK5ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142102-A9 CONOTOXIN PEPTIDE ANALOGS AND USES FOR THE TREATMENT OF PAIN AND INFLAMMATORY CONDITIONS KINETA CHRONIC PAIN, LLC (US) 2020-11-19 WO disclosed
WO-2020142102-A1 CONOTOXIN PEPTIDE ANALOGS AND USES FOR THE TREATMENT OF PAIN AND INFLAMMATORY CONDITIONS KINETA CHRONIC PAIN, LLC (US) 2020-07-09 WO disclosed